Evidence map›Paper›PMID 32927859›Full record

ArticleCells2020

Maria V Guijarro, Laura S Danielson, Marta Cañamero, Akbar Nawab, Carolina Abrahan, Eva Hernando, Glyn D Palmer

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cells, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. TSC2 is a stress granule suppressor.bioRxiv : the preprint server for biology · 2026
    Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Role of TSC1 in physiology and diseases.Molecular and cellular biochemistry · 2021
    Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Maria V GuijarroDepartment of Pathology, NYU Grossman School of Medicine, NYU Langone Health, New York, NY 10016, USA.
Laura S DanielsonDepartment of Pathology, NYU Grossman School of Medicine, NYU Langone Health, New York, NY 10016, USA.
Marta CañameroRoche Pharmaceutical Research and Early Development, Translational Medicine Oncology, Roche Innovation Center Penzberg, Nonnenwald, 282377 Penzberg, Germany.
Akbar NawabDepartment of Anatomy and Cell Biology, University of Florida, Gainesville, FL 32610, USA.
Carolina AbrahanDepartment of Orthopaedics and Rehabilitation, University of Florida, Gainesville, FL 32610, USA.ORCID 0000-0003-2529-6533
Eva HernandoDepartment of Pathology, NYU Grossman School of Medicine, NYU Langone Health, New York, NY 10016, USA.
Glyn D PalmerDepartment of Orthopaedics and Rehabilitation, University of Florida, Gainesville, FL 32610, USA.
University of Florida · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

TSC1 is a tumor suppressor that inhibits cell growth via negative regulation of the mammalian target of rapamycin complex (mTORC1).

Indexed as

Cell ProliferationAnimalsCell DifferentiationCells, CulturedCellular SenescenceFemaleMesenchymal Stem CellsMiceMice, KnockoutTOR Serine-Threonine KinasesTuberous SclerosisTuberous Sclerosis Complex 1 ProteinmTOR protein, mouseTOR Serine-Threonine KinasesTsc1 protein, mouseTuberous Sclerosis Complex 1 Proteinmammalian target of rapamycin (mTOR)mesenchymal stem cellsenescencestem cell proliferationTSC1tuberous sclerosis

Identifiers

PMID32927859
PMCPMC7565438
OpenAlexW3084315064

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.